MANAGEMENT OF CONDYLOMATA ACUMINATA WITH ALFERON-N INJECTION, INTERFERON ALFA-N3 (HUMAN-LEUKOCYTE DERIVED)

被引：23
|
作者：
FRIEDMANKIEN, A [1 ]
机构：
[1] NYU, MED CTR, DEPT DERMATOL, NEW YORK, NY 10016 USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1995年 / 172卷 / 04期
关键词：
D O I：
10.1016/0002-9378(95)90404-2
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：1359 / 1368
页数：10
相关论文
共 26 条
  • [1] INTRALESIONAL ADMINISTRATION OF LARGE DOSES OF HUMAN-LEUKOCYTE INTERFERON FOR THE TREATMENT OF CONDYLOMATA ACUMINATA
    GEFFEN, JR
    KLEIN, RJ
    FRIEDMANKIEN, AE
    JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (04): : 612 - 615
  • [2] NATURAL HUMAN-LEUKOCYTE INTERFERON (INTERFERON ALFA-N3) CONTAINS INTERFERON ALPHA-2B, NOT ALPHA-2A OR ALPHA-2C
    DIPAOLA, M
    OGIN, E
    SMITH, TA
    MARCOTTE, J
    LEE, SY
    FERENCZBIRO, K
    LIAO, MJ
    TESTA, D
    FASEB JOURNAL, 1992, 6 (01): : A342 - A342
  • [3] TREATMENT OF ADVANCED CONDYLOMATA ACUMINATA WITH SEMI-PURIFIED AND PURIFIED HUMAN-LEUKOCYTE INTERFERON
    EINHORN, N
    LING, P
    SECHER, D
    STRANDER, H
    ACTA ONCOLOGICA, 1991, 30 (03) : 343 - 345
  • [4] Dose-finding study of interferon alfa-n3 in hepatitis C
    Hoofnagle, JH
    Everhart, J
    HEPATOLOGY, 1997, 26 (05) : 1366 - 1367
  • [5] Treatment of HCV/HIV coinfection with leukocyte derived interferon alfa-n3.
    Sherman, KE
    Lalezari, J
    Brand, JD
    Yoffe, B
    Yangco, B
    Fedorczyk, D
    GASTROENTEROLOGY, 2000, 118 (04) : A1487 - A1487
  • [6] CHANGES IN SERUM-LIPIDS IN PATIENTS WITH CONDYLOMATA ACUMINATA TREATED WITH INTERFERON ALFA-N1 (WELLFERON)
    OLSEN, EA
    LICHTENSTEIN, GR
    WILKINSON, WE
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (02) : 286 - 289
  • [7] Dose-finding study of interferon alfa-n3 in hepatitis C - Reply
    Simon, DM
    HEPATOLOGY, 1997, 26 (05) : 1367 - 1367
  • [8] Neuropsychological effects of Interferon Alfa-n3 treatment in asymptomatic human immunodeficiency virus-1-infected individuals
    Mapou, RL
    Law, WA
    Wagner, K
    Malone, JL
    Skillman, DR
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1996, 8 (01) : 74 - 81
  • [9] Interferon Sciences starts Phase III trials of IFN alfa-n3 in chronic hepatitis C
    不详
    BIOTECHNOLOGY LAW REPORT, 1996, 15 (05): : 705 - 705
  • [10] Management of interferon-β1b (Betaseron) failures in multiple sclerosis with interferon-αn3 (Alferon N)
    Sheremata, WA
    Minagar, A
    EARLY INDICATORS, EARLY TREATMENTS, NEUROPROTECTION IN MULTIPLE SCLEROSIS, 2003, : 191 - 195
123